Non-glycosylated A-SAA has been identified as being locally expressed in normal tissue cells, tumor cells, chronic obstructive pulmonary disease, rheumatoid synovial tissues, atherosclerotic plaques, and neuroinflammatory lesions in the brains of Alzheimer’s disease patients. Here, SAA2 is linked to Alzheimer disease.